The age at which you can start hormone therapy FTM (female-to-male) varies depending on the country or state you live in. In the United States, the Endocrine Society recommends that transgender youth can start hormone therapy at the age of 16, with parental consent. However, some healthcare providers may be willing to start hormone therapy at a younger age, depending on the individual’s circumstances.

There are a number of factors that healthcare providers will consider when deciding whether or not to start hormone therapy for a transgender youth, including the youth’s age, maturity level, and mental health status. They will also want to make sure that the youth has had a chance to explore their gender identity and to make an informed decision about hormone therapy.

If you are a transgender youth who is considering hormone therapy, it is important to talk to a healthcare provider who is experienced in treating transgender people. They can help you to discuss your options and to make the best decision for you.

Here are some additional resources that you may find helpful:
⦁ The World Professional Association for Transgender Health (WPATH):
⦁ The Trevor Project:
⦁ Trans Lifeline:

The age at which individuals can start hormone therapy for female-to-male (FTM) transition varies depending on various factors, including medical guidelines, individual circumstances, and the practices of healthcare professionals. Here are some general considerations:
⦁ Age of Consent: In many countries, the age of medical consent is typically 18 years or older. This means that individuals who have reached the age of consent can legally make decisions about their own healthcare, including hormone therapy. However, the age of consent may vary by jurisdiction, so it is important to be aware of the laws and regulations in your specific location.
⦁ Guidelines and Recommendations: Various medical organizations and guidelines provide recommendations on the initiation of hormone therapy for FTM individuals. For example, the World Professional Association for Transgender Health (WPATH) Standards of Care suggests a minimum age of 16 years for hormone therapy, with a requirement for a comprehensive assessment by a qualified healthcare professional experienced in transgender healthcare.
⦁ Individual Assessment: The decision to start hormone therapy for FTM transition is made on an individual basis, taking into account factors such as physical and emotional maturity, capacity for informed consent, and overall well-being. Mental health professionals and healthcare providers experienced in transgender healthcare typically assess individuals seeking hormone therapy to ensure they have a good understanding of the potential benefits, risks, and long-term implications of treatment.
⦁ Pubertal Suppression: For individuals who express a strong desire to transition prior to reaching the age of medical consent, the option of pubertal suppression may be considered. Pubertal suppression involves the use of medications, such as GnRH analogs, to temporarily halt the development of secondary sexual characteristics associated with the individual’s assigned sex at birth. This approach allows more time for exploration and reflection before making irreversible decisions about hormone therapy.

It is important to consult with qualified healthcare professionals, such as endocrinologists or healthcare providers specializing in transgender healthcare, who can evaluate your individual circumstances, assess your readiness for hormone therapy, and provide appropriate guidance and support. They will take into account the specific guidelines, laws, and best practices in your jurisdiction to determine the most suitable age to initiate hormone therapy for FTM transition.